149 related articles for article (PubMed ID: 21173715)
1. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma.
Kuo YW; Jerng JS; Shih JY; Chen KY; Yu CJ; Yang PC
J Thorac Oncol; 2011 Feb; 6(2):378-83. PubMed ID: 21173715
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study.
Ball D; Thursfield V; Irving L; Mitchell P; Richardson G; Torn-Broers Y; Wright G; Giles G
Lung Cancer; 2013 Nov; 82(2):358-61. PubMed ID: 24051083
[TBL] [Abstract][Full Text] [Related]
4. Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.
Hsu CL; Chen JH; Chen KY; Shih JY; Yang JC; Yu CJ; Yang PC
J Geriatr Oncol; 2015 Jan; 6(1):38-45. PubMed ID: 25245172
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study.
Alexander M; Evans SM; Stirling RG; Wolfe R; Officer A; MacManus M; Solomon B; Burbury K; Ball D
J Thorac Oncol; 2016 May; 11(5):748-757. PubMed ID: 26851495
[TBL] [Abstract][Full Text] [Related]
9. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
[TBL] [Abstract][Full Text] [Related]
10. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
11. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
13. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M; Kanda S; Koizumi T
Chemotherapy; 2019; 64(3):129-137. PubMed ID: 31622969
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and prognostic factors of small cell lung cancer: A retrospective study in 148 patients.
Cai Q; Luo HL; Gao XC; Xiong CJ; Tong F; Zhang RG; Hu Y; Wu G; Dong XR
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):916-922. PubMed ID: 27924504
[TBL] [Abstract][Full Text] [Related]
15. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base.
Combs SE; Hancock JG; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
J Thorac Oncol; 2015 Feb; 10(2):316-23. PubMed ID: 25319182
[TBL] [Abstract][Full Text] [Related]
16. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.
Colinet B; Jacot W; Bertrand D; Lacombe S; Bozonnat MC; Daurès JP; Pujol JL;
Br J Cancer; 2005 Nov; 93(10):1098-105. PubMed ID: 16234816
[TBL] [Abstract][Full Text] [Related]
17. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
18. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
19. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
